cognitive deficits

The Contributing Factors to Poor Sleep Experiences in According to the University Students: A Cross-Sectional Study.

The contributing factors to poor sleep experiences in according to the university students: A cross-sectional study.

J Res Med Sci. 2012 Jun; 17(6): 557-61
Altun I, C?nar N, Dede C

Sleep problems among university students are common; however, the… Continue reading

Cognitive Enhancement Therapy for Adults With Autism Spectrum Disorder: Results of an 18-Month Feasibility Study.

Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-month Feasibility Study.

J Autism Dev Disord. 2013 Apr 26;
Eack SM, Greenwald DP, Hogarty SS, Bahorik AL, Litschge MY, Mazefsky CA, Minshew NJ

Adults with autism… Continue reading

Shame and Guilt in Social Anxiety Disorder: Effects of Cognitive Behavior Therapy and Association With Social Anxiety and Depressive Symptoms.

Shame and guilt in social anxiety disorder: effects of cognitive behavior therapy and association with social anxiety and depressive symptoms.

PLoS One. 2013; 8(4): e61713
Hedman E, Ström P, Stünkel A, Mörtberg E

Social anxiety disorder (SAD), characterized by… Continue reading

Symptomatic Hallucal Interphalangeal Sesamoid Bones Successfully Treated With Ultrasound-Guided Injection – a Case Report -.

Symptomatic Hallucal Interphalangeal Sesamoid Bones Successfully Treated with Ultrasound-guided Injection – A Case Report -.

Korean J Pain. 2013 Apr; 26(2): 173-6
Shin HY, Park SY, Kim HY, Jung YS, An S, Kang do H

The hallucal interphalangeal sesamoid… Continue reading

Alcohol Use and Cerebral White Matter Compromise in Adolescence.

Alcohol use and cerebral white matter compromise in adolescence.

Addict Behav. 2013 Mar 15; 38(7): 2295-2305
Elofson J, Gongvatana W, Carey KB

Alcohol use is typically initiated during adolescence, a period known to be critical in neurodevelopment. The adolescent… Continue reading

Molecular Aging of the Brain, Neuroplasticity, and Vulnerability to Depression and Other Brain-Related Disorders.

Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders.

Dialogues Clin Neurosci. 2013 Mar; 15(1): 53-65
Sibille E

The increased risk for neurodegenerative and neuropsychiatric disorders associated with extended lifespan has long suggested mechanistic… Continue reading

ASAM Magazine: The Voice of Addiction Medicine.

ASAM Magazine: The Voice of Addiction Medicine.

J Addict Med. 2013 Mar-Apr; 7(2): 150-1

HubMed – addiction

 

The impact of prenatal alcohol exposure on addiction treatment.

J Addict Med. 2013 Mar-Apr; 7(2): 87-95
Grant TM, Brown NN,… Continue reading

A Prospective Study of Neurocognitive Changes 15 Years After Chronic Inhalant Abuse.

A prospective study of neurocognitive changes 15 years after chronic inhalant abuse.

Addiction. 2013 Mar 13;
Cairney S, O’ Connor N, Dingwall KM, Maruff P, Shafiq-Antonacci R, Currie J, Currie BJ

AIMS: In a previous study, neurological and cognitive deficits reflecting central nervous system (CNS) disruption from chronic inhalant abuse showed substantial recovery after 2 years’ abstinence. Functional recovery was progressive, with recovery rates dependent on the degree of impairment prior to abstinence, and severity and duration of initial abuse. Persistent deficits occurred in those with previous ‘lead encephalopathy’ from leaded petrol abuse. The current study examined recovery in the same cohort 15 years after baseline. DESIGN: Prospective cohort design. SETTING: Two remote Aboriginal communities in Arnhem Land, Australia. PARTICIPANTS: Using baseline group classifications, 27 healthy controls, 60 ex-chronic inhalant abusers and an additional 17 with previous lead encephalopathy were assessed. MEASUREMENTS: Standard neurological, ocular-motor and cognitive functions and blood lead levels. FINDINGS: Chronic (non-encephalopathic) inhalant abusers showed elevated blood lead levels and abnormal scores on most tasks at baseline. At 2 years’ abstinence, blood lead was reduced but remained elevated and most scores had normalized. By 15 years, blood lead and all performance scores were equivalent to healthy controls for this group (P?>?0.05). The encephalopathic group was more severely impaired… Continue reading

Melatonin and Its Agonists in Pain Modulation and Its Clinical Application.

Melatonin and its agonists in pain modulation and its clinical application.

Arch Ital Biol. 2012 Dec; 150(4): 274-92
Srinivasan V, Zakaria R, Jeet Singh H, Acuna-Castroviejo D

Melatonin, the hormone of darkness has many physiological functions in the body… Continue reading

Occurrence of Cognitive Impairment and Depressive Symptoms Among the Elderly in a Nursing Home Facility.

Occurrence of cognitive impairment and depressive symptoms among the elderly in a nursing home facility.

Adv Clin Exp Med. 2013 Jan-Feb; 22(1): 111-7
Kowalska J, Rymaszewska J, Szczepa?ska-Gieracha J

The aim of the study was to assess the occurence… Continue reading